Reviewed by Michael Gill, B. Sc.
Image of Centre Hospitalier Universitaire de Sherbrooke in Sherbrooke, Canada.
Phase-Based Progress Estimates

Interventionfor Surgery

Patients undergoing laparoscopic surgery suffer in 30-85% of cases of referred pain in the shoulder in the first days following their intervention. Pain can be disabling and may even delay the discharge of patients. Several techniques have been proposed to reduce this problem. Promising strategies include the reduction of CO2 insufflation flow, lung recruitment maneuvers and active aspiration of intraperitoneal air at the end of surgical procedure to force gas discharge. The investigators wish to perform a randomized controlled trial with 160 women, who will assess the effect of a combined approach, combining for the first time lung recruitment maneuvers and aspiration of pneumoperitoneum in the Trendelenburg position at the end of surgery and flow of insufflation reduces carbon dioxide (CO2) forming the pneumoperitoneum during surgery, on the intensity of shoulder pain postoperatively. In the control group the evacuation of the pneumoperitoneum will be done by opening the trocars and external abdominal pressure at the end of surgery. No study to our knowledge has tested the active aspiration maneuvers gas after laparoscopic surgery in gynecology. The study will be preceded by a pilot study in 15 participants, who will be assigned to the control group to determine the basic rate of referred pain in the shoulder in our people and improve test management.
Waitlist Available
Has No Placebo
Centre Hospitalier Universitaire de SherbrookeJean-Charles Pasquier, MD, PhD
25 Surgery Clinical Trials Near Me
Top Hospitals for Surgery Clinical Trials
Top Cities for Surgery Clinical Trials
Image of Anchorage in Alaska.
65Active Trials
Katmai Oncology GroupTop Active Site
Image of Denver in Colorado.
52Active Trials
Porter Adventist HospitalTop Active Site
Surgery Clinical Trials by Phase of Trial
Phase < 1 Surgery Clinical Trials
10Active Surgery Clinical Trials
10Number of Unique Treatments
7Number of Active Locations
ChemotherapyCisplatinDiagnostic (fluciclovine F18 PET/CT)Arm I (tranexamic acid)propranolol hydrochlorideStereotactic RadiosurgeryKetoconazoleAllon System